Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
First-line nivolumab plus ipilimumab versus chemotherapy in patients with unresectable malignant pleural mesothelioma: 3-year outcomes from CheckMate 743
PaperCitations, authors & open-access status
First-line nivolumab plus ipilimumab versus chemotherapy in patients with unresectable malignant pleural mesothelioma: 3-year outcomes from CheckMate 743 is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 266 citations, 2022 year and hybrid oa status.
266
Citations
2022
Year
hybrid
OA Status